Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Harte

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|January 29, 2002
A review of molecular modeling approaches to pharmacophore models and structure-activity relationships of ion channel modulators in CNSY Li, W E Harte
Methods in Enzymology|January 1, 1994
Probing structure-function relationships in human immunodeficiency virus type 1 protease via molecular dynamics simulationW E Harte, D L Beveridge
Proteins|July 11, 1992
Molecular dynamics of HIV-1 proteaseW E Harte, S Swaminathan, D L Beveridge
Biochemical and Biophysical Research Communications|March 10, 1991
Structural studies of the anti-HIV agent 2',3'-didehydro-2',3'-dideoxythymidine (D4T)W E Harte, J E Starrett, J C Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Domain communication in the dynamical structure of human immunodeficiency virus 1 proteaseW E Harte, S Swaminathan, M M Mansuri, et al.
Journal of Medicinal Chemistry|November 1, 1990
Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsS Y Sit, R A Parker, I Motoc, et al.
Journal of Virology|May 1, 1997
Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virusG Luo, A Torri, W E Harte, et al.
Journal of Medicinal Chemistry|November 5, 1997
Sulfated galactocerebrosides as potential antiinflammatory agentsA Marinier, A Martel, J Banville, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
4-Thiazolidinones: novel inhibitors of the bacterial enzyme MurBC J Andres, J J Bronson, S V D'Andrea, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|January 29, 2002
A review of molecular modeling approaches to pharmacophore models and structure-activity relationships of ion channel modulators in CNSY Li, W E Harte
Methods in Enzymology|January 1, 1994
Probing structure-function relationships in human immunodeficiency virus type 1 protease via molecular dynamics simulationW E Harte, D L Beveridge
Proteins|July 11, 1992
Molecular dynamics of HIV-1 proteaseW E Harte, S Swaminathan, D L Beveridge
Biochemical and Biophysical Research Communications|March 10, 1991
Structural studies of the anti-HIV agent 2',3'-didehydro-2',3'-dideoxythymidine (D4T)W E Harte, J E Starrett, J C Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Domain communication in the dynamical structure of human immunodeficiency virus 1 proteaseW E Harte, S Swaminathan, M M Mansuri, et al.
Journal of Medicinal Chemistry|November 1, 1990
Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsS Y Sit, R A Parker, I Motoc, et al.
Journal of Virology|May 1, 1997
Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virusG Luo, A Torri, W E Harte, et al.
Journal of Medicinal Chemistry|November 5, 1997
Sulfated galactocerebrosides as potential antiinflammatory agentsA Marinier, A Martel, J Banville, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
4-Thiazolidinones: novel inhibitors of the bacterial enzyme MurBC J Andres, J J Bronson, S V D'Andrea, et al.
Pageof 1